CN112772723A - Formula of milk powder beneficial to development of immune system of children and production method thereof - Google Patents
Formula of milk powder beneficial to development of immune system of children and production method thereof Download PDFInfo
- Publication number
- CN112772723A CN112772723A CN202110020226.8A CN202110020226A CN112772723A CN 112772723 A CN112772723 A CN 112772723A CN 202110020226 A CN202110020226 A CN 202110020226A CN 112772723 A CN112772723 A CN 112772723A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- powder
- milk
- formula
- milk powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 120
- 235000013336 milk Nutrition 0.000 title claims abstract description 93
- 239000008267 milk Substances 0.000 title claims abstract description 93
- 210000004080 milk Anatomy 0.000 title claims abstract description 93
- 210000000987 immune system Anatomy 0.000 title claims abstract description 30
- 230000009286 beneficial effect Effects 0.000 title claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 32
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 30
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 28
- 239000006041 probiotic Substances 0.000 claims abstract description 28
- 235000018291 probiotics Nutrition 0.000 claims abstract description 28
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 claims abstract description 25
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims abstract description 25
- 210000003022 colostrum Anatomy 0.000 claims abstract description 25
- 235000021277 colostrum Nutrition 0.000 claims abstract description 25
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 24
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 24
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 22
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 22
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 22
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 18
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 16
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 16
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 16
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000016804 zinc Nutrition 0.000 claims abstract description 16
- 239000011701 zinc Substances 0.000 claims abstract description 16
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 16
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 15
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 15
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 15
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 15
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 15
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 15
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 15
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960000304 folic acid Drugs 0.000 claims abstract description 14
- 235000019152 folic acid Nutrition 0.000 claims abstract description 14
- 239000011724 folic acid Substances 0.000 claims abstract description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 14
- 239000008158 vegetable oil Substances 0.000 claims abstract description 14
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 13
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 13
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 13
- 229960002477 riboflavin Drugs 0.000 claims abstract description 13
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 12
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 12
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 12
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 12
- 229960001231 choline Drugs 0.000 claims abstract description 12
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 12
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims abstract description 12
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 12
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 12
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 12
- 239000011719 vitamin A Substances 0.000 claims abstract description 12
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 12
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 12
- 239000011718 vitamin C Substances 0.000 claims abstract description 12
- 229940045997 vitamin a Drugs 0.000 claims abstract description 12
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 12
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000011669 selenium Substances 0.000 claims abstract description 11
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 11
- 235000011649 selenium Nutrition 0.000 claims abstract description 11
- 229940091258 selenium supplement Drugs 0.000 claims abstract description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 10
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 10
- 239000005862 Whey Substances 0.000 claims abstract description 10
- 239000011575 calcium Substances 0.000 claims abstract description 10
- 229960005069 calcium Drugs 0.000 claims abstract description 10
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 10
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 10
- 229960003284 iron Drugs 0.000 claims abstract description 10
- 229910052742 iron Inorganic materials 0.000 claims abstract description 10
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 10
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 10
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 10
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 10
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 9
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 9
- 235000020958 biotin Nutrition 0.000 claims abstract description 9
- 239000011616 biotin Substances 0.000 claims abstract description 9
- 229960002685 biotin Drugs 0.000 claims abstract description 9
- 239000008101 lactose Substances 0.000 claims abstract description 9
- 239000011777 magnesium Substances 0.000 claims abstract description 9
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 9
- 229940091250 magnesium supplement Drugs 0.000 claims abstract description 9
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 9
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 9
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 9
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 9
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 9
- 235000020610 powder formula Nutrition 0.000 claims abstract description 9
- 229960003495 thiamine Drugs 0.000 claims abstract description 9
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 9
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 9
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 9
- 239000011710 vitamin D Substances 0.000 claims abstract description 9
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 9
- 229940046008 vitamin d Drugs 0.000 claims abstract description 9
- 235000020247 cow milk Nutrition 0.000 claims abstract description 8
- 235000020251 goat milk Nutrition 0.000 claims abstract description 8
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 6
- 229930003448 Vitamin K Natural products 0.000 claims abstract description 3
- 239000004519 grease Substances 0.000 claims abstract description 3
- 235000019168 vitamin K Nutrition 0.000 claims abstract description 3
- 239000011712 vitamin K Substances 0.000 claims abstract description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 claims abstract description 3
- 229940046010 vitamin k Drugs 0.000 claims abstract description 3
- 235000013350 formula milk Nutrition 0.000 claims description 43
- 241000283690 Bos taurus Species 0.000 claims description 31
- 238000002156 mixing Methods 0.000 claims description 26
- 238000003860 storage Methods 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 11
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 235000018102 proteins Nutrition 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 9
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 9
- 235000019175 phylloquinone Nutrition 0.000 claims description 9
- 239000011772 phylloquinone Substances 0.000 claims description 9
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 9
- 229960001898 phytomenadione Drugs 0.000 claims description 9
- 235000020183 skimmed milk Nutrition 0.000 claims description 9
- 235000008939 whole milk Nutrition 0.000 claims description 9
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 8
- 230000001737 promoting effect Effects 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
- 235000010755 mineral Nutrition 0.000 claims description 7
- 239000011707 mineral Substances 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 235000021049 nutrient content Nutrition 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 claims description 3
- 230000004071 biological effect Effects 0.000 claims description 3
- 229940072440 bovine lactoferrin Drugs 0.000 claims description 3
- 235000013325 dietary fiber Nutrition 0.000 claims description 3
- 238000007580 dry-mixing Methods 0.000 claims description 3
- 235000019197 fats Nutrition 0.000 claims description 3
- 238000005243 fluidization Methods 0.000 claims description 3
- 235000020191 long-life milk Nutrition 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000011265 semifinished product Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 235000019871 vegetable fat Nutrition 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 230000000529 probiotic effect Effects 0.000 claims description 2
- 241000194035 Lactococcus lactis Species 0.000 claims 1
- 230000036039 immunity Effects 0.000 description 20
- 230000018109 developmental process Effects 0.000 description 16
- 241000700605 Viruses Species 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 11
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 11
- 210000001744 T-lymphocyte Anatomy 0.000 description 9
- 210000003719 b-lymphocyte Anatomy 0.000 description 8
- 244000057717 Streptococcus lactis Species 0.000 description 7
- 235000013365 dairy product Nutrition 0.000 description 7
- 210000002865 immune cell Anatomy 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 235000019156 vitamin B Nutrition 0.000 description 5
- 239000011720 vitamin B Substances 0.000 description 5
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
- 230000009545 invasion Effects 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 210000001539 phagocyte Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- RZALONVQKUWRRY-FYZOBXCZSA-N 2,3-dihydroxybutanedioic acid;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound OC(=O)C(O)C(O)C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O RZALONVQKUWRRY-FYZOBXCZSA-N 0.000 description 3
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 3
- 235000019743 Choline chloride Nutrition 0.000 description 3
- 235000000638 D-biotin Nutrition 0.000 description 3
- 239000011665 D-biotin Substances 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 229960003563 calcium carbonate Drugs 0.000 description 3
- 235000010216 calcium carbonate Nutrition 0.000 description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 3
- 229960003178 choline chloride Drugs 0.000 description 3
- 235000000639 cyanocobalamin Nutrition 0.000 description 3
- 239000011666 cyanocobalamin Substances 0.000 description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 3
- 229960001781 ferrous sulfate Drugs 0.000 description 3
- 239000011790 ferrous sulphate Substances 0.000 description 3
- 235000003891 ferrous sulphate Nutrition 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 229960002337 magnesium chloride Drugs 0.000 description 3
- 235000011147 magnesium chloride Nutrition 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 3
- 229960000342 retinol acetate Drugs 0.000 description 3
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 3
- 235000019173 retinyl acetate Nutrition 0.000 description 3
- 239000011770 retinyl acetate Substances 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 229960001471 sodium selenite Drugs 0.000 description 3
- 239000011781 sodium selenite Substances 0.000 description 3
- 235000015921 sodium selenite Nutrition 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 235000020238 sunflower seed Nutrition 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 3
- 239000011747 thiamine hydrochloride Substances 0.000 description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 description 3
- 235000005282 vitamin D3 Nutrition 0.000 description 3
- 239000011647 vitamin D3 Substances 0.000 description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 3
- 229940021056 vitamin d3 Drugs 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 3
- 229960001763 zinc sulfate Drugs 0.000 description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 description 3
- 241000283707 Capra Species 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000711920 Human orthopneumovirus Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000714177 Murine leukemia virus Species 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000034435 immune system development Effects 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/231—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a milk powder formula beneficial to development of immune systems of children, which comprises cow/goat milk, whey powder, lactose, cow colostrum powder, vegetable oil, fructo-oligosaccharide, galacto-oligosaccharide, docosahexaenoic acid grease, L-carnitine, lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics, choline, magnesium, calcium, iron, zinc, selenium, vitamin A, vitamin D, vitamin K, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, nicotinic acid, folic acid, pantothenic acid and biotin.
Description
Technical Field
The invention relates to the field of modified milk powder, in particular to a formula of milk powder beneficial to development of an immune system of children and a production method thereof, and particularly relates to a formula of modified milk powder suitable for 3-year-old children, aiming at improving the immunity of the children or improving the development of the immune system of the children.
Background
The immune system is the most fundamental and effective mechanism for the human body to resist the invasion of external bacteria, viruses and harmful substances and to eliminate the self-produced harmful substances in the body. For children, the immune system is not mature, the prime phase of development of the immune system of children is before 16 years old, and besides sleeping and moving, sufficient nutrition supplement is very important.
The dairy product is rich in high-quality protein, vitamins and minerals such as calcium, iron, zinc and the like for children over 3 years old, and is a very ideal nutritional supplement. The dairy product supplement of 300 plus 400ml per day for preschool children and the dairy product supplement of 300ml per day for school-age children are recommended in the book "Chinese resident meal index finger south 2016" compiled by the Chinese Nutrition society.
At present, the dairy products on the market are various and can be roughly divided into liquid milk such as pure milk, yoghourt, children milk and the like and milk powder dairy products such as whole milk powder, children milk powder and the like. The liquid milk and the children milk powder in the market are relatively low in nutrition added additionally, and particularly at present, the children are difficult to meet the nutritional requirements of the children due to the fact that the phenomenon of monophagia of the children is increasingly serious. And less dairy products with strong pertinence and help immune system development, and the market needs more accurate and more targeted child dairy products with more nutrient addition. However, due to national regulations, the nutrient types of liquid milk are allowed to be added in a limited way, the nutrient addition range of the children milk powder is wider, and the children milk powder with high pertinence and accurate nutrition is a development direction in the future.
Human immunity is the most effective way to combat unknown diseases. In children, due to immaturity of the immune system and lack of knowledge about hygiene and disease, the ability to fight disease is weaker than in adults, the ability to fight unknown disease is worse, the immune system is enhanced, resistance is provided, and the most urgent need is for children.
Disclosure of Invention
The invention relates to a formula of milk powder beneficial to development of immune systems of children, which comprises cow/goat milk, whey powder, lactose, cow colostrum powder, vegetable oil, fructo-oligosaccharide, galacto-oligosaccharide, docosahexaenoic acid grease, L-carnitine, lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics, choline, magnesium, calcium, iron, zinc, selenium, vitamin A, vitamin D, vitamin K, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, nicotinic acid, folic acid, pantothenic acid and biotin.
Preferably, the bovine colostrum powder is added in an amount of 1-10 g per 100g of milk powder.
Preferably, the addition amount of the N-acetylneuraminic acid is 10-50mg/100g of milk powder.
Preferably, the addition amount of the yeast beta-glucan is 30-100mg/100g milk powder.
Preferably, the probiotic bacteria are bifidobacterium lactis, lactobacillus rhamnosus, and lactobacillus lactis subsp.
Preferably, 10 hundred million CFU of Bifidobacterium lactis, 10 hundred CFU of Lactobacillus rhamnosus and 10 hundred million CFU of lactococcus lactis subspecies lactis are added to every 100g of milk powder.
The nutrient content of the milk powder is as follows:
in another aspect, the invention relates to a method for producing a milk powder formula which is beneficial to the development of the immune system of children, comprising the following steps:
1) adding liquid milk: according to the formula requirement, introducing a specified amount of purified raw cow/goat milk or whole fat/skimmed milk into a milk storage tank 1; if the formula does not use liquid milk, adding treated purified water;
2) redissolving and treating the main materials: adding the pretreated purified water into the blending tank 1, adding solid raw materials such as whole milk powder, skimmed milk powder, whey powder, lactose and the like according to the formula requirement, stirring to completely dissolve, and introducing into the milk storage tank 1;
3) adding vegetable oil: adding vegetable oil into a milk storage tank 1 according to the formula requirement;
4) dissolving dietary fiber: adding fructo-oligosaccharide and galacto-oligosaccharide into the blending tank 2 according to the formula requirement, stirring to dissolve completely, and introducing into the milk storage tank 1;
5) dissolving the vitamins: adding vitamin A, vitamin D, vitamin C, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, biotin, choline and L-carnitine into a dissolving tank 2 according to the formula requirements, stirring to completely dissolve, and then introducing into a milk storage tank 1;
6) dissolving minerals: adding calcium, magnesium, iron, zinc and selenium into the dissolving tank 2 according to the formula requirements, stirring to completely dissolve, and then introducing into the milk storage tank 1;
7) and (3) sterilization: sterilizing the mixed solution through a pipeline at the temperature of 121-135 ℃;
8) homogenizing: homogenizing the sterilized milk liquid under 10-14 Mpa;
9) concentrating and drying: firstly, carrying out reduced pressure concentration, wherein the vacuum degree is 46-87Kpa, and the concentration is 15-27-degree Ba; the air inlet temperature is 165-190 ℃ and the air outlet temperature is 68-94 ℃, so that the biological activity and the nutrient content of most of proteins in the production process of the formula milk powder are ensured; finally, fluidized bed drying is carried out, the air inlet temperature is 35-95 ℃, and the fluidization speed is 0.05-3.5 m/s;
10) adding other raw materials: uniformly mixing lactoferrin, bovine colostrum powder, N-acetylneuraminic acid, yeast beta-glucan, probiotics and DHA with the semi-finished milk powder according to the formula requirement in a ratio of 1:10, adding a dry mixer, and stirring for 20-40 min;
11) packaging: filling the stirred finished product powder in a clean workshop;
the bovine colostrum powder can be added in step 10); the bovine colostrum powder, N-acetylneuraminic acid, yeast beta-glucan and DHA can also be added in step 5).
Alternatively, a method for producing a milk powder formula beneficial to the development of the immune system of children comprises the following steps:
1) unpacking: removing external package of raw materials such as customized vegetable fat powder (vegetable oil, whey powder), whole milk powder, skimmed milk powder, etc., and placing the internal package into a workshop for temporarily storing raw materials in a cleaning area by air showering and ultraviolet sterilization;
2) weighing small materials: according to the formula requirements, weighing and subpackaging vitamins, mineral substances, L-carnitine, choline, fructo-oligosaccharide, galacto-oligosaccharide, bovine colostrum powder, lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics and DHA small materials, sterilizing the surfaces of packages, and then sending the packages into a mixing workshop for later use;
3) mixing small materials 1: uniformly mixing lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics and DHA with the semi-finished milk powder according to the proportion of 1:10 respectively;
4) mixing small materials 2: uniformly mixing fructo-oligosaccharide, galacto-oligosaccharide and semi-finished product according to the ratio of 1: 10;
5) mixing raw materials: adding vitamin A, vitamin D, vitamin C, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, biotin, choline, L-carnitine, calcium, magnesium, iron, zinc and selenium, the mixed powder obtained in the step 3) and the bovine colostrum powder into the semi-finished milk powder according to the formula requirements, adding a dry mixing machine, and stirring for 20-40 min;
6) packaging: and filling the stirred finished product powder in a clean workshop.
Advantageous effects
The human immune system can be divided into specific immunity (acquired immunity) and non-specific immunity (innate immunity)
Specific immunity:
specific immunity is an acquired defense function gradually established after birth of a human body, and is characterized in that the specific immunity is generated after birth and only acts on a specific pathogen or foreign matter, so the specific immunity is called as specific immunity and acquired immunity.
The specific immunity mainly comprises immune organs (thymus, lymph nodes, spleen and the like) and immune cells (lymphocytes), and comprises humoral immunity of B lymphocyte mediated conductors and T lymphocyte mediated cellular immunity;
b cells, also called B lymphocytes, are cells capable of producing antibodies against each particular invader or antigen. When a B cell is contacted with an antigen, it rapidly divides more B cells and releases antibodies that lock tightly against the invader, prevent the invader from entering human cells and producing toxins, and recruit immune legionella T cells.
T cells, also called T lymphocytes, can be classified as helper T lymphocytes, suppressor T lymphocytes and NK lymphocytes (natural killer cells), which can produce cytotoxins to destroy invaders. Helper T lymphocytes can help activate B cells, enhancing their sensitivity to invaders; when the immune system wins, the T lymphocyte can be inhibited to turn off the immune reaction, so as to avoid the over-excitation of the immune reaction and the loss of the self cell.
Non-specific immunity:
the natural defense function of non-specific immune human body is gradually established in the course of evolution, and is characterized by that it is not aimed at a specific pathogen, and has the defense effect for several pathogens. Including skin and mucous membranes, bactericidal substances, phagocytic cells, etc.
Skin and mucous membrane include external skin and internal mucous membrane of digestive tract, respiratory tract and other mucous membrane tissues, which not only can prevent pathogens from invading human body, but also their secretions (such as lactic acid, fatty acid, gastric acid and enzyme, etc.) have bactericidal effect. Cilia are formed on the respiratory mucosa to remove foreign matters.
The bactericidal substance and phagocyte include bactericidal substances such as lactoferrin and lysozyme in body fluid and intestinal tract, and immunocyte such as phagocyte, killer cell and dendritic cell.
Macrophages are phagocytic cells that engulf and digest invaders that have been recognized by B and T cells, thereby completely ending the immune war.
In most cases, nonspecific immunity prevents the invasion of pathogens into the body.
The invention relates to a milk powder formula beneficial to helping the development of an immune system of children and a production method of a related technology.
1. Specific immunity
1) Sufficient B vitamins and zinc and selenium are added.
The rapid generation of B cells and T cells, and the development of normal immunity, are not separated from B vitamins and zinc and selenium. Especially, vitamin B6, folic acid and zinc can help the generation of immune cells, the generation of antibodies can not be separated from vitamin B6, and the lack of other B vitamins can inhibit the immune function.
The formula of the vitamin B complex can meet the requirement of more than 60% of B vitamins such as vitamin B6, folic acid and the like required by Chinese children every day, and particularly, the most easily lacked vitamin B2 and vitamin B12 can reach 80% of the daily required amount of the children. The zinc can basically meet the daily basic requirements of Chinese children.
2) Yeast beta-glucan was added.
The yeast beta-glucan can stimulate and enhance the phagocytic activity of immune cells such as NK lymphocytes and macrophages, enhance the capability of killing harmful substances, stimulate T cells to proliferate to generate more NK lymphocytes and stimulate B cells to generate more antibodies.
3) Adding bovine colostrum powder.
Bovine colostrum powder contains a large number of immunologically active substances, including active substances such as immunoglobulin G (antibody), lysozyme, nucleotides, etc. The immune substances can inhibit and kill harmful bacteria and viruses.
4) 3 kinds of probiotics are added.
About 70% of human immune cells are located in the intestinal tract, and probiotics in the intestinal tract can stimulate functional maturation of the immune cells to play a role of a trainer. The combination of multiple species of probiotics can enhance a wider variety of immune cells. The accuracy and the high efficiency of the specific immunity of the immune cells are improved.
The probiotics can quickly proliferate in intestinal tract to form dominant bacteria, inhibit proliferation of harmful bacteria in intestinal tract by survival competition, reduce disease treatment probability of harmful bacteria, and play a role in nonspecific immunity
5) 2 prebiotics (fructo-oligosaccharides + galacto-oligosaccharides) were added.
The prebiotics can not be absorbed by human body, but can be absorbed and utilized by the probiotics, so that more food is provided for the probiotics, the probiotics are helped to quickly proliferate, and the dominant bacteria are formed. And the prebiotics form acidic substances after being utilized by the probiotics, and inhibit the proliferation of harmful bacteria.
2. Specific immunity
1) Adding N-acetylneuraminic acid.
The virus invades human mucosal cells by the specific combination of the marker protein on the surface of the virus and the N-acetylneuraminic acid on the marker protein on the surface of the mucosal cells, so that the virus invades the cells. The virus surface identification protein is a key, the mucosal cell surface identification protein is a door, the N-acetylneuraminic acid on the mucosal cell surface identification protein is a lock, and the virus can enter the mucosal cell by opening the door by opening the N-acetylneuraminic acid lock. The method is characterized in that free N-acetylneuraminic acid is added to be combined with identification protein (key) of the virus in advance, so that the virus cannot be combined with human mucosal cells, the mucosa is protected, invasion of the virus is reduced, immunity is enhanced, and resistance is improved.
2) Vitamin A, vitamin C and zinc are sufficient.
Vitamin A and vitamin C can maintain skin elasticity, reduce skin injury, maintain skin and mucosa integrity and health, and prevent invasion of harmful substances such as bacteria and virus.
Most harmful bacteria generate free radicals, and destroy skin and mucosa barriers through strong oxidation of the free radicals, so that the harmful bacteria invade the human body. Vitamin A, vitamin C, zinc, etc. are antioxidants, can effectively remove free radicals, and protect the health of skin and mucosa.
3) Lactoferrin was added.
Lactoferrin can bind iron element, thereby reducing the absorption of iron, an essential element, by bacteria and affecting the growth of harmful bacteria. And can be used for resisting various viruses such as I type and II type herpes simplex virus, cytomegalovirus, human immunodeficiency virus, hepatitis C virus, hantavirus, rotavirus, I type poliomyelitis virus, human respiratory syncytial virus, murine leukemia virus, etc.
Drawings
FIG. 1 is a method of producing a milk powder for promoting the development of the immune system of a child according to an embodiment of the present invention;
FIG. 2 is a method for preparing milk powder to promote the development of the immune system of children in another embodiment of the present invention.
Detailed Description
The invention relates to milk powder beneficial to development of immune systems of children, a specific preparation method of the milk powder can adopt a dry-wet compounding method process, a flow schematic diagram is shown in figure 1, and the milk powder comprises the following steps:
1) adding liquid milk: according to the formula requirements, a specified amount of purified raw cow/goat milk or whole fat/skim milk is introduced into a milk storage tank 1 (if liquid milk is not used in the formula, purified water is added).
2) Redissolving and treating the main materials: adding the pretreated purified water into the blending tank 1, adding the solid raw materials such as whole milk powder, skimmed milk powder, whey powder, lactose and the like according to the formula requirement, stirring to completely dissolve, and introducing into the milk storage tank 1. (bovine colostrum powder can be added in step 10)
3) Adding vegetable oil: according to the formula requirements, vegetable oil is added into the milk storage tank 1.
4) Dissolving dietary fiber: adding fructo-oligosaccharide and galacto-oligosaccharide into the blending tank 2 according to the formula requirement, stirring to dissolve completely, and introducing into the milk storage tank 1.
5) Dissolving the vitamins: according to the formula requirements, vitamin A, vitamin D, vitamin C, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, biotin, choline and L-carnitine are added into a dissolving tank 2, stirred to be completely dissolved and then introduced into a milk storage tank 1.
6) Dissolving minerals: adding calcium, magnesium, ferrum, zinc and selenium into the dissolving tank 2 according to the formula requirements, stirring to completely dissolve, and introducing into the milk storage tank 1.
7) And (3) sterilization: the mixed solution is sterilized through a pipeline at the temperature of 121-135 ℃.
8) Homogenizing: homogenizing the sterilized milk under 10-14 Mpa.
9) Concentrating and drying: firstly, carrying out reduced pressure concentration, wherein the vacuum degree is 46-87Kpa, and the concentration is 15-27-degree Ba; the air inlet temperature is 165-190 ℃ and the air outlet temperature is 68-94 ℃, so that the biological activity and the nutrient content of most of proteins in the production process of the formula milk powder are ensured; finally, fluidized bed drying is carried out, the air inlet temperature is 35-95 ℃, and the fluidization speed is 0.05-3.5 m/s.
10) Adding other raw materials: according to the formula requirements, lactoferrin, bovine colostrum powder, N-acetylneuraminic acid, yeast beta-glucan, probiotics and DHA are respectively and uniformly mixed according to the proportion of 1:10 to (semi-finished milk powder), and then added into a dry mixer to be stirred for 20-40 min. (bovine colostrum powder, N-acetylneuraminic acid, yeast beta-glucan, DHA can also be added in step 5)
11) Packaging: and filling the stirred finished product powder in a clean workshop.
Optionally or alternatively, the milk powder preparation process provided by the invention adopts a dry process, and comprises the following steps:
1) unpacking: the raw materials such as the customized vegetable fat powder (vegetable oil, whey powder), the whole milk powder, the skimmed milk powder and the like are taken out of the outer package according to the required amount of the formula, and the inner package enters a workshop for temporarily placing the raw materials in a cleaning area through wind showering and ultraviolet sterilization.
2) Weighing small materials: according to the formula requirements, the vitamins, minerals, L-carnitine, choline, fructo-oligosaccharide, galacto-oligosaccharide, bovine colostrum powder, lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics, DHA and other small materials are weighed and subpackaged, and are sent to a mixing workshop for standby after being packaged and surface sterilized.
3) Mixing small materials 1: uniformly mixing lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics and DHA in a ratio of 1:10 to the semi-finished milk powder respectively.
4) Mixing small materials 2: and uniformly mixing the fructo-oligosaccharide, the galacto-oligosaccharide and the semi-finished product according to the ratio of 1: 10.
5) Mixing raw materials: adding vitamin A, vitamin D, vitamin C, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, biotin, choline, L-carnitine, calcium, magnesium, iron, zinc and selenium, the mixed powder obtained in the step 3) and the bovine colostrum powder into the semi-finished milk powder according to the formula requirements, adding a dry mixing machine, and stirring for 20-40 min. .
6) Packaging: and filling the stirred finished product powder in a clean workshop.
In actual production, a factory can change the adding sequence and the process parameters of the raw materials according to actual conditions, and the whole process flow can be completed in one factory or multiple factories.
Example 1 milk powder for promoting development of immune system of children
Preparing materials:
the milk powder comprises: whole milk, cow/goat milk powder, cow/goat whey protein powder, lactose, cow colostrum powder (added amount: 1-10 g/100g milk powder), vegetable oil (sunflower seed oil, soybean oil), fructo-oligosaccharide, galacto-oligosaccharide, docosahexaenoic acid oil, L-carnitine tartrate, lactoferrin, N-acetylneuraminic acid (added amount: 10-50mg/100g milk powder), yeast beta-glucan (added amount: 30-100mg/100g milk powder), probiotics (Bifidobacterium lactis, Lactobacillus rhamnosus, lactococcus lactis subspecies lactis), choline chloride, magnesium chloride, calcium carbonate, ferrous sulfate, zinc sulfate, sodium selenite, vitamin A acetate, cholecalciferol, phytomenadione, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, cyanocobalamine, L-ascorbic acid, nicotinamide, folic acid, D-calcium pantothenate, D-biotin:
every 100g of milk powder is added with 10 hundred million CFU of bifidobacterium lactis, 10 hundred million CFU of lactobacillus rhamnosus and 10 hundred million of CFU of lactococcus lactis subspecies lactis
The type and amount of the probiotics can be adjusted according to actual conditions.
Nutrient composition table:
example 2 milk powder for promoting development of immune system of children
The milk powder comprises: raw cow/goat milk, cow/goat whey protein powder, lactose, cow colostrum powder (added amount: 1-10 g/100g milk powder), vegetable oil (sunflower seed oil, soybean oil), fructo-oligosaccharide, galacto-oligosaccharide, docosahexaenoic acid oil, L-carnitine tartrate, lactoferrin, N-acetylneuraminic acid (added amount: 10-50mg/100g milk powder), yeast beta-glucan (added amount: 30-100mg/100g milk powder), probiotics (bifidobacterium lactis, lactobacillus rhamnosus, lactococcus lactis subspecies lactis), choline chloride, magnesium chloride, calcium carbonate, ferrous sulfate, zinc sulfate, sodium selenite, vitamin A acetate, cholecalciferol, phytomenadione, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, cyanocobalamine, L-ascorbic acid, nicotinamide, folic acid, calcium D-pantothenate, D-biotin;
every 100g of milk powder is added with 10 hundred million CFU of bifidobacterium lactis, 10 hundred million CFU of lactobacillus rhamnosus and 10 hundred million of CFU of lactococcus lactis subspecies lactis.
The type and amount of the probiotics can be adjusted according to actual conditions.
Nutrient composition table:
example 3 milk powder for promoting development of immune system of children
The milk powder comprises: high oil whey powder (bovine/sheep whey protein powder, sunflower seed oil, soybean oil), whole milk powder, lactose, bovine colostrum powder (added amount: 1-10 g/100g milk powder), fructo-oligosaccharide, galacto-oligosaccharide, docosahexaenoic acid oil, L-carnitine tartrate, lactoferrin, N-acetylneuraminic acid (added amount: 10-50mg/100g milk powder), yeast beta-glucan (added amount: 30-100mg/100g milk powder), probiotics (Lactobacillus lactis, Lactobacillus rhamnosus, lactococcus lactis subspecies lactis), choline chloride, magnesium chloride, calcium carbonate, ferrous sulfate, zinc sulfate, sodium selenite, vitamin A acetate, cholecalciferol, phytomenadione, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, cyanocobalamin, L-ascorbic acid, nicotinamide, folic acid, calcium D-pantothenate, D-biotin;
every 100g of milk powder is added with 10 hundred million CFU of bifidobacterium lactis, 10 hundred million CFU of lactobacillus rhamnosus and 10 hundred million of CFU of lactococcus lactis subspecies lactis.
The type and amount of the probiotics can be adjusted according to actual conditions.
Nutrient composition table:
the process and formulation of this patent can be adjusted appropriately according to national regulations, changes in standards and actual conditions of the manufacturing plant without changing the final result.
Claims (9)
1. The formula of the milk powder beneficial to development of the immune system of children is characterized by comprising cow/goat milk, whey powder, lactose, cow colostrum powder, vegetable oil, fructo-oligosaccharide, galacto-oligosaccharide, docosahexaenoic acid grease, L-carnitine, lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics, choline, magnesium, calcium, iron, zinc, selenium, vitamin A, vitamin D, vitamin K, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, nicotinic acid, folic acid, pantothenic acid and biotin.
2. The milk powder formula for promoting development of immune system of children according to claim 1, wherein the bovine colostrum powder is added in an amount of 1-10 g/100g milk powder.
3. The formula of milk powder for promoting development of immune system of children as claimed in claim 1 or 2, wherein the amount of N-acetylneuraminic acid added is 10-50mg/100g of milk powder.
4. The milk powder formula for promoting development of immune system of children as claimed in claim 1 or 2, wherein the yeast β -glucan is added in an amount of 30-100mg/100g milk powder.
5. The milk powder formulation for the development of the immune system of children according to claim 1 or 2, wherein the probiotic bacteria are bifidobacterium lactis andor lactobacillus rhamnosus andor lactobacillus lactis subsp.
6. The formula of claim 5, wherein 10 million CFU of Bifidobacterium lactis, 10 million CFU of Lactobacillus rhamnosus, and 10 million CFU of lactococcus lactis subspecies lactis are added per 100g of the formula.
8. method for the production of a milk powder formula for the development of the immune system of children according to the preceding claims, comprising the following steps:
1) adding liquid milk: according to the formula requirement, introducing a specified amount of purified raw cow/goat milk or whole fat/skimmed milk into a milk storage tank 1; if the formula does not use liquid milk, adding treated purified water;
2) redissolving and treating the main materials: adding the pretreated purified water into the blending tank 1, adding solid raw materials such as whole milk powder, skimmed milk powder, whey powder, lactose and the like according to the formula requirement, stirring to completely dissolve, and introducing into the milk storage tank 1;
3) adding vegetable oil: adding vegetable oil into a milk storage tank 1 according to the formula requirement;
4) dissolving dietary fiber: adding fructo-oligosaccharide and galacto-oligosaccharide into the blending tank 2 according to the formula requirement, stirring to completely dissolve, and introducing into the milk storage tank 1;
5) dissolving the vitamins: adding vitamin A, vitamin D, vitamin C, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, biotin, choline and L-carnitine into a dissolving tank 2 according to the formula requirements, stirring to completely dissolve, and then introducing into a milk storage tank 1;
6) dissolving minerals: adding calcium, magnesium, iron, zinc and selenium into the dissolving tank 2 according to the formula requirements, stirring to completely dissolve, and then introducing into the milk storage tank 1;
7) and (3) sterilization: sterilizing the mixed solution through a pipeline at the temperature of 121-135 ℃;
8) homogenizing: homogenizing the sterilized milk liquid under 10-14 Mpa;
9) concentrating and drying: firstly, carrying out reduced pressure concentration, wherein the vacuum degree is 46-87Kpa, and the concentration is 15-27-degree Ba; the air inlet temperature is 165-190 ℃ and the air outlet temperature is 68-94 ℃, so that the biological activity and the nutrient content of most of proteins in the production process of the formula milk powder are ensured; finally, fluidized bed drying is carried out, the air inlet temperature is 35-95 ℃, and the fluidization speed is 0.05-3.5 m/s;
10) adding other raw materials: uniformly mixing lactoferrin, bovine colostrum powder, N-acetylneuraminic acid, yeast beta-glucan, probiotics and DHA with the semi-finished milk powder according to the formula requirement in a ratio of 1:10, adding a dry mixer, and stirring for 20-40 min;
11) packaging: filling the stirred finished product powder in a clean workshop;
the bovine colostrum powder can be added in step 10); the bovine colostrum powder, N-acetylneuraminic acid, yeast beta-glucan and DHA can also be added in step 5).
9. Method for the production of a milk powder formula for the development of the immune system of children according to the preceding claims, comprising the following steps:
1) unpacking: removing external package of raw materials such as customized vegetable fat powder (vegetable oil, whey powder), whole milk powder, skimmed milk powder, etc., and allowing the internal package to enter into a workshop for temporarily storing raw materials in clean area by air showering and ultraviolet sterilization;
2) weighing small materials: according to the formula requirements, weighing and subpackaging vitamins, mineral substances, L-carnitine, choline, fructo-oligosaccharide, galacto-oligosaccharide, bovine colostrum powder, lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics and DHA small materials, packaging, sterilizing the surface, and then sending into a mixing workshop for later use;
3) mixing small materials 1: uniformly mixing lactoferrin, N-acetylneuraminic acid, yeast beta-glucan, probiotics and DHA with the semi-finished milk powder according to the proportion of 1:10 respectively;
4) mixing small materials 2: uniformly mixing fructo-oligosaccharide, galacto-oligosaccharide and semi-finished product according to the ratio of 1: 10;
5) mixing raw materials: adding vitamin A, vitamin D, vitamin C, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, pantothenic acid, biotin, choline, L-carnitine, calcium, magnesium, iron, zinc and selenium, the mixed powder obtained in the step 3) and the bovine colostrum powder into the semi-finished milk powder according to the formula requirements, adding a dry mixing machine, and stirring for 20-40 min;
6) packaging: and filling the stirred finished product powder in a clean workshop.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110020226.8A CN112772723A (en) | 2021-01-07 | 2021-01-07 | Formula of milk powder beneficial to development of immune system of children and production method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110020226.8A CN112772723A (en) | 2021-01-07 | 2021-01-07 | Formula of milk powder beneficial to development of immune system of children and production method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112772723A true CN112772723A (en) | 2021-05-11 |
Family
ID=75756072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110020226.8A Pending CN112772723A (en) | 2021-01-07 | 2021-01-07 | Formula of milk powder beneficial to development of immune system of children and production method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112772723A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2532062A1 (en) * | 2005-01-14 | 2006-07-14 | Nutrinor Cooperative Agro-Alimentaire Du Saguenay Lac St-Jean | Food composition for maintaining and restoring digestive functions |
CN104413334A (en) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | Edible composition as well as preparation method and application thereof |
CN111184072A (en) * | 2020-03-02 | 2020-05-22 | 上海育博营养食品有限公司 | Milk powder beneficial to enhancing immunity and improving resistance and production method thereof |
-
2021
- 2021-01-07 CN CN202110020226.8A patent/CN112772723A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2532062A1 (en) * | 2005-01-14 | 2006-07-14 | Nutrinor Cooperative Agro-Alimentaire Du Saguenay Lac St-Jean | Food composition for maintaining and restoring digestive functions |
CN104413334A (en) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | Edible composition as well as preparation method and application thereof |
CN111184072A (en) * | 2020-03-02 | 2020-05-22 | 上海育博营养食品有限公司 | Milk powder beneficial to enhancing immunity and improving resistance and production method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111184072A (en) | Milk powder beneficial to enhancing immunity and improving resistance and production method thereof | |
CN106578092A (en) | Children milk powder and making method thereof | |
RU2740156C1 (en) | Methods for improving growth of useful bacteria in gastrointestinal tract | |
CN103053692A (en) | Lactoferrin and nucleotide-added baby formula goat milk powder and preparation method thereof | |
CN103917106A (en) | Partially hydrolyzed casein-whey nutritional compositions for reducing onset of allergies | |
CA2822892C (en) | Method for inhibiting pathogens using a nutritional composition | |
EP2658396A1 (en) | Use of nutritional compositions including lactoferrin in stimulating immune cells | |
CN108450555A (en) | A kind of shield tooth infant's formula milk and preparation method thereof | |
CN112772722A (en) | Formula and production method of milk powder for helping skeleton and height development of children | |
CN112167360A (en) | Low-sensitization infant formula goat milk powder | |
CN106720456A (en) | Solid beverage composition containing WPC and preparation method thereof | |
CN108669563A (en) | A kind of composition, its application and strengthen immunity, the product for improving allergy | |
CN111587923A (en) | An infant formula containing sialic acid and its preparation method | |
CN114128767B (en) | Milk protein partially hydrolyzed hypoallergenic infant formulas containing breast milk oligosaccharides | |
WO2020260502A1 (en) | COMPOSITIONS COMPRISING SECRETORY IgA AND PROBIOTICS | |
CN101953468B (en) | Collagen peptide-containing lactic acid bacterium powder | |
CN105076417A (en) | Intestine protective formula milk powder and preparation method thereof | |
US8648036B2 (en) | Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract | |
TWI620506B (en) | Use of yoghurt and method of manufacturing same | |
CN101803695B (en) | Calcium and iron supplement product being applicable to children | |
CN112075504A (en) | Infant formula milk powder for enhancing immunity | |
CN112772723A (en) | Formula of milk powder beneficial to development of immune system of children and production method thereof | |
CN105638907A (en) | Infant formula milk powder capable of improving immunity | |
CN114532406A (en) | Formula milk powder for improving human immunity and preparation method and application thereof | |
CN112704234A (en) | Nutritional composition containing composite peptide and probiotics and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210511 |
|
RJ01 | Rejection of invention patent application after publication |